Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives

References

• ShieldsMKAdlerPAFuzzardDRChalasaniRTeongJMA case of acute bilateral Irvine-Gass syndrome following uncomplicated phacoemulsification, demonstrated with optical coherence tomographyCase Rep Ophthalmol20156114314826034486
   PubMedGoogle Scholar
• SinghRAlpernLJaffeGJEvaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathyClin Ophthalmol201261259126922927737
   PubMedGoogle Scholar
• IrvineSRA newly defined vitreous syndrome following cataract surgeryAm J Ophthalmol195336559961913040458
   PubMed Web of Science ®Google Scholar
• MunkMRJampolLMSimaderCDifferentiation of diabetic macular edema from pseudophakic cystoid macular edema by spectral-domain optical coherence tomographyInvest Ophthalmol Vis Sci201556116724673326567783
   PubMed Web of Science ®Google Scholar
• ChuCJJohnstonRLBuscombeCSallamABMohamedQYangYCUnited Kingdom Pseudophakic Macular Edema Study GroupRisk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyesOphthalmology2016123231632326681390
   PubMed Web of Science ®Google Scholar
• GarciaJMIsaacDLÁvilaMPDexamethasone 0.7 mg implants in the management of pseudophakic cystoid macular edemaArq Bras Oftalmol201679211311527224076
   PubMed Web of Science ®Google Scholar
• SinghRPLehmannRMartelJNepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized Phase 3 studiesOphthalmology2017124677678528268098
   PubMed Web of Science ®Google Scholar
• McCaffertySHarrisAKewCPseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placeboBMC Ophthalmol20171711628219426
   PubMed Web of Science ®Google Scholar
• WieldersLHSchoutenJSAberleMRTreatment of cystoid macular edema after cataract surgeryJ Cataract Refract Surg201743227628428366377
   PubMed Web of Science ®Google Scholar
• MedićAJukićTMatasAVukojevićKSapunarAZnaorLEffect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trialCroat Med J2017581495528252875
   PubMed Web of Science ®Google Scholar
• ShorsteinNHLiuLWaxmanMDHerrintonLJComparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgeryOphthalmology2015122122450245626409728
   PubMed Web of Science ®Google Scholar
• MakriOETsapardoniFNPlotasPIfantisNXanthopoulouPTGeorgakopoulosCDCystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literatureBMC Res Notes201710112728320481
   PubMedGoogle Scholar
• DoJROhJHChuckRSParkCYTransient corneal edema is a predictive factor for pseudophakic cystoid macular edema after uncomplicated cataract surgeryKorean J Ophthalmol2015291142225646056
   PubMedGoogle Scholar
• YangJCaiLSunZRisk factors for and diagnosis of pseudophakic cystoid macular edema after cataract surgery in diabetic patientsJ Cataract Refract Surg201743220721428366368
   PubMed Web of Science ®Google Scholar
• RamakrishnanSBaskaranPTalwarBVenkateshRProspective, randomized study comparing the effect of 0.1% nepafenac and 0.4% ketorolac tromethamine on macular thickness in cataract surgery patients with low risk for cystoid macular edemaAsia Pac J Ophthalmol (Phila)20154421622026225780
   PubMedGoogle Scholar
• PollackAStaurenghiGSagerDMukeshBReiserHSinghRPProspective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathyBr J Ophthalmol2017101442342727388251
   PubMed Web of Science ®Google Scholar
• SarfrazMHHaqRIMehboobMAEffect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathyPak J Med Sci201733121021428367202
   PubMed Web of Science ®Google Scholar
• GekkaMMiyataKNagaiYCorneal epithelial barrier function in diabetic patientsCornea2004231353714701955
   PubMed Web of Science ®Google Scholar
• SainiJSMittalSIn vivo assessment of corneal endothelial function in diabetes mellitusArch Ophthalmol199611466496538639073
   PubMedGoogle Scholar
• ChenXYSongWJCaiHYZhaoLMacular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomographyInt J Ophthalmol201691818526949615
   PubMed Web of Science ®Google Scholar
• SchmierJKCovertDWHulme-LoweCKMullinsAMahlisEMTreatment costs of cystoid macular edema among patients following cataract surgeryClin Ophthalmol20161047748327041989
   PubMed Web of Science ®Google Scholar
• TzelikisPVieiraMAlvesMComparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised studyBr J Ophthalmol201599565465825385061
   PubMed Web of Science ®Google Scholar
• AlmeidaDRKhanZXingLProphylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsificationJ Cataract Refract Surg20123891537154322795976
   PubMed Web of Science ®Google Scholar
• MathysKCCohenKLImpact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedemaEye (Lond)2010241909619229275
   PubMed Web of Science ®Google Scholar
• TsilimbarisMKTsikaCKymionisGDIntravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgeryTher Clin Risk Manag20161217718226929630
   PubMed Web of Science ®Google Scholar
• YükselBUzunelUDKerciSGSagbanLKusbeciTOrselTComparison of subtenon triamcinolone acetonide injection with topical nepafenac for the treatment of pseudophakic cystoid macular edemaOcul Immunol Inflamm20162517
   Web of Science ®Google Scholar
• BosciaFGiancipoliED’Amico RicciGPinnaAManagement of macular oedema in diabetic patients undergoing cataract surgeryCurr Opin Ophthalmol2017281232827661663
   PubMed Web of Science ®Google Scholar
• LimBXLimCHLimDKEvansJRBunceCWormaldRProphylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgeryCochrane Database Syst Rev201611CD00668327801522
   PubMedGoogle Scholar
• ModjtahediBSPaschalJFBatechMLuongTQFongDSPerioperative topical nonsteroidal anti-inflammatory drugs for macular edema prophylaxis following cataract surgeryAm J Ophthalmol201717617418228104415
   PubMed Web of Science ®Google Scholar
• KimSJSchoenbergerSDThorneJEEhlersJPYehSBakriSJTopical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of OphthalmologyOphthalmology2015122112159216826123091
   PubMed Web of Science ®Google Scholar
• KesselLTendalBJørgensenKJPost-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic reviewOphthalmology2014121101915192424935281
   PubMed Web of Science ®Google Scholar
• ChastainJESandersMECurtisMADistribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eyeExp Eye Res2016145586726474497
   PubMed Web of Science ®Google Scholar
• HariprasadSMCallananDGaineySHeYGWarrenKCystoid and diabetic macular edema treated with nepafenac 0.1%J Ocul Pharmacol Ther200723658559018001248
   PubMed Web of Science ®Google Scholar
• KapinMAYanniJMBradyMTInflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenacInflammation200327528129114635785
   PubMed Web of Science ®Google Scholar
• CardasciaNPalmisanoCCentoducatiTAlessioGTopical non-steroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgeryInt Ophthalmol Epub20161020
   Web of Science ®Google Scholar
• LoftssonTSigurdssonHHKonrádsdóttirFGísladóttirSJansookPStefánssonETopical drug delivery to the posterior segment of the eye: anatomical and physiological considerationsPharmazie200863317117918444504
   PubMed Web of Science ®Google Scholar
• SigurdssonHHKonráethsdóttirFLoftssonTStefánssonETopical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eyeActa Ophthalmol Scand200785659860217645424
   PubMedGoogle Scholar
• ModiSSLehmannRPWaltersTROnce-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 studyJ Cataract Refract Surg201440220321124345529
   PubMed Web of Science ®Google Scholar